๐
Aliqopa
copanlisib
Lymphoma, B-Cell, Marginal Zone
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment of adult patients with relapsed marginal zone lymphoma
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/aliqopa